Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1639  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (760 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this Article
   Article Figures

 Article Access Statistics
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal


Table of Contents    
Year : 2021  |  Volume : 69  |  Issue : 4  |  Page : 1114-1115

Long Vertebral Arteritis and Cerebellar Infarction caused by Suspected Giant Cell Arteritis

Department of Neurology, Nagano Red Cross Hospital, Wakasato, Nagano, Japan

Date of Submission02-Jul-2018
Date of Decision29-Jun-2020
Date of Acceptance09-Jul-2020
Date of Web Publication2-Sep-2021

Correspondence Address:
Yuya Kobayashi
Department of Neurology, Nagano Red Cross Hospital, 5-22-1, Wakasato, Nagano, 380-8582
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0028-3886.325359

Rights and Permissions

How to cite this article:
Kobayashi Y, Sato S, Takamatsu R, Ishii W. Long Vertebral Arteritis and Cerebellar Infarction caused by Suspected Giant Cell Arteritis. Neurol India 2021;69:1114-5

How to cite this URL:
Kobayashi Y, Sato S, Takamatsu R, Ishii W. Long Vertebral Arteritis and Cerebellar Infarction caused by Suspected Giant Cell Arteritis. Neurol India [serial online] 2021 [cited 2022 Jan 23];69:1114-5. Available from:

A 79-year-old Japanese man was admitted with pulsatile headache and ataxia. He had polymyalgia rheumatica and had been taking prednisolone (12 mg/day). Magnetic resonance imaging (MRI) revealed cerebellar infarction and right vertebral artery stenosis [Figure 1]a and [Figure 1]b. Aspirin and argatroban were started. MRI on day 7 revealed new cerebellar infarction. His erythrocyte sedimentation rate was 26 mm/h, and he had pulsatile headache, suggesting giant cell arteritis (GCA) related to polymyalgia rheumatica. The right vertebral artery was enhanced on MRI, proving arteritis [Figure 1]c. Arterial dissection was suspected, but it was ruled out because of circumferential wall thickening and absence of false lumen formation. All collagen-related markers including ANCA-related disease were negative. Biopsy of the temporal artery revealed no histological finding. This case did not meet GCA criteria[1] because it was based on temporal arteritis; however, GCA was strongly suspected. We increased the amount of prednisolone to 30 mg/day recommended dose.[2] He had no recurrence; however, the finding on MRI persisted. No further immunosuppressive therapy was administered because the patient was elderly and had experienced bleeding due to intestinal candidiasis.
Figure 1: (a) On admission, cerebellar infarction was detected on diffusion-weighted magnetic resonance imaging (arrow). (b) Magnetic resonance angiography revealed a long right vertebral artery stenosis. (c) The right vertebral artery was enhanced along a long region (arrow). Positron emission tomography investigation could not be performed due to his economic situations. Computed tomographic angiography and digital subtraction angiography were impossible because of contrast agent allergy

Click here to view

In this case, a long stenotic lesion developed only in the vertebral artery, and it was resistant to steroid therapy. GCA occurs in only 0.15% cerebral infarction cases.[3] Postcirculatory cerebral infarction with headache suggests arterial dissection. In patients with GCA, vertebrobasilar infarction is the most common type.[4] GCA should be suspected, and contrast MRI is recommended. The main strategy is to use corticosteroids. However, steroid treatment is ineffective or causes a new infarction in some cases.[4] Other immunosuppressive therapies, such as cyclophosphamide, tocilizumab, and methotrexate, have also been reported.[4]

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Hunder G, Bloch D, Michel B, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.  Back to cited text no. 1
Watelet B, Samson M, de Boysson H, Bienvenu B. Treatment of giant-cell arteritis, a literature review. Mod Rheumatol 2017;27:747-54.  Back to cited text no. 2
Thielen KR, Wijdicks EF, Nichols DA. Giant cell (temporal) arteritis: Involvement of the vertebral and internal carotid arteries. Mayo Clinic Proc 1998;73:444-6.  Back to cited text no. 3
Haisa T, Tsuda T, Hagiwara K, Kikuchi T, Seki K. Vertebrobasilar infarction related to giant cell (temporal) arteritis: Case report. Neurol Med Chir (Tokyo) 2015;55:95-100.  Back to cited text no. 4


  [Figure 1]


Print this article  Email this article
Online since 20th March '04
Published by Wolters Kluwer - Medknow